Special considerations in treating children with epilepsy

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

The incidence of seizures is high in infants and children. Many epileptic syndromes have their onset early in life. The increase in seizure susceptibility of the immature brain may be due to several factors, including an imbalance between excitatory and inhibitory processes, age-specific differences in ionic transport and clearance systems, high incidence of epileptogenic stimuli early in life, and the age-specific expression of pre- and perinatal brain anomalies. All of these factors must be taken into account when developing safe and effective age-specific antiepileptic drugs (AEDs). The use of developmental epilepsy models, followed by clinical trials in children, may help identify such AEDs.

Original languageEnglish (US)
JournalPharmacotherapy
Volume20
Issue number8 II
StatePublished - 2000

Fingerprint

Anticonvulsants
Epilepsy
Seizures
Incidence
Brain
Clinical Trials

ASJC Scopus subject areas

  • Pharmacology (medical)
  • Pharmacology, Toxicology and Pharmaceutics(all)

Cite this

Special considerations in treating children with epilepsy. / Moshe, Solomon L.

In: Pharmacotherapy, Vol. 20, No. 8 II, 2000.

Research output: Contribution to journalArticle

@article{41545dba3759459488a910af1d87fa88,
title = "Special considerations in treating children with epilepsy",
abstract = "The incidence of seizures is high in infants and children. Many epileptic syndromes have their onset early in life. The increase in seizure susceptibility of the immature brain may be due to several factors, including an imbalance between excitatory and inhibitory processes, age-specific differences in ionic transport and clearance systems, high incidence of epileptogenic stimuli early in life, and the age-specific expression of pre- and perinatal brain anomalies. All of these factors must be taken into account when developing safe and effective age-specific antiepileptic drugs (AEDs). The use of developmental epilepsy models, followed by clinical trials in children, may help identify such AEDs.",
author = "Moshe, {Solomon L.}",
year = "2000",
language = "English (US)",
volume = "20",
journal = "Pharmacotherapy",
issn = "0277-0008",
publisher = "Pharmacotherapy Publications Inc.",
number = "8 II",

}

TY - JOUR

T1 - Special considerations in treating children with epilepsy

AU - Moshe, Solomon L.

PY - 2000

Y1 - 2000

N2 - The incidence of seizures is high in infants and children. Many epileptic syndromes have their onset early in life. The increase in seizure susceptibility of the immature brain may be due to several factors, including an imbalance between excitatory and inhibitory processes, age-specific differences in ionic transport and clearance systems, high incidence of epileptogenic stimuli early in life, and the age-specific expression of pre- and perinatal brain anomalies. All of these factors must be taken into account when developing safe and effective age-specific antiepileptic drugs (AEDs). The use of developmental epilepsy models, followed by clinical trials in children, may help identify such AEDs.

AB - The incidence of seizures is high in infants and children. Many epileptic syndromes have their onset early in life. The increase in seizure susceptibility of the immature brain may be due to several factors, including an imbalance between excitatory and inhibitory processes, age-specific differences in ionic transport and clearance systems, high incidence of epileptogenic stimuli early in life, and the age-specific expression of pre- and perinatal brain anomalies. All of these factors must be taken into account when developing safe and effective age-specific antiepileptic drugs (AEDs). The use of developmental epilepsy models, followed by clinical trials in children, may help identify such AEDs.

UR - http://www.scopus.com/inward/record.url?scp=0033854204&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033854204&partnerID=8YFLogxK

M3 - Article

C2 - 10937816

AN - SCOPUS:0033854204

VL - 20

JO - Pharmacotherapy

JF - Pharmacotherapy

SN - 0277-0008

IS - 8 II

ER -